EP2729173
Meðferð sem beinist gegn EGFR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.7.2012EP published:
15.6.2016EP application number:
12758888.7
EP translation filed:
30.8.2016Grant published:
15.9.2016EPO information:
European Patent Register
Max expiry date:
4.7.2032Expiry date:
4.7.2026Next due date:
31.7.2026
Title:
EGFR TARGETED THERAPY
Timeline
Today
5.7.2012EP application
15.6.2016EP Publication
30.8.2016Translation submitted
15.9.2016Registration published
4.7.2026Expires
Owner
Name:
Marte Grønlie CameronAddress:
Major Laudalsvei 33, 4633 Kristiansand S, NO
Name:
Christian KerstenAddress:
Maudsvei 98, 4633 Kristiansand S, NO
Name:
Svein MjålandAddress:
Skippergata 104, 4633 Kristiansand S, NO
Inventor
Name:
KERSTEN, ChristianAddress:
Kristiansand, NO
Name:
CAMERON, Marte, GronlieAddress:
Kristiansand, NO
Name:
MJALAND, SveinAddress:
Kristiansand, NO
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161504737 PDate:
6.7.2011Country:
US
Classification
Categories:
A61K 39/395, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 8.8.2016
Expires: 4.7.2017
Payer: Árnason Faktor
Number: 6
Paid: 7.6.2017
Expires: 4.7.2018
Payer: Árnason Faktor
Number: 7
Paid: 7.6.2018
Expires: 4.7.2019
Payer: Árnason Faktor
Number: 8
Paid: 5.6.2019
Expires: 4.7.2020
Payer: Árnason Faktor
Number: 9
Paid: 12.6.2020
Expires: 4.7.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 21.7.2021
Expires: 4.7.2022
Payer: Patice ehf.
Number: 11
Paid: 18.7.2022
Expires: 4.7.2023
Payer: Patice ehf.
Number: 12
Paid: 27.7.2023
Expires: 4.7.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 17.7.2024
Expires: 4.7.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 18.7.2025
Expires: 4.7.2026
Payer: Árnason Faktor ehf.